findmyKOL
Clinical trialNCT01586858TerminatedObservational

Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

SponsorJohns Hopkins UniversityEnrollment67Granulomatosis With PolyangiitisMicroscopic Polyangiitis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Rituximab is the first drug approved by the United States Food and Drug Administration (FDA) for the treatment of patients with granulomatosis with polyangiitis (Wegener's granulomatosis) or microscopic polyangiitis. Because it is a relatively new medication, the long-term safety and efficacy of this drug is not yet clear. This study proposes to follow patients who were enrolled in the RAVE study to determine if treatment with rituximab influences long-term outcomes.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Netherlands
  • University Hospital Groningen

    Groningen, Netherlands

United States
  • University of Alabama

    Birmingham, Alabama, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Boston University

    Boston, Massachusetts, United States

  • Mayo Clinic Foundation

    Rochester, Minnesota, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • the Cleveland Clinic

    Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2012
Primary completion
15 May 2014
Completion
15 May 2014
Last update posted
27 Oct 2017
Registered enrollment
67
Registry id
NCT01586858
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.